全文获取类型
收费全文 | 18968篇 |
免费 | 1836篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 221篇 |
儿科学 | 585篇 |
妇产科学 | 552篇 |
基础医学 | 2496篇 |
口腔科学 | 472篇 |
临床医学 | 2380篇 |
内科学 | 3456篇 |
皮肤病学 | 449篇 |
神经病学 | 1604篇 |
特种医学 | 593篇 |
外国民族医学 | 1篇 |
外科学 | 2496篇 |
综合类 | 368篇 |
一般理论 | 23篇 |
预防医学 | 2309篇 |
眼科学 | 363篇 |
药学 | 1283篇 |
中国医学 | 20篇 |
肿瘤学 | 1158篇 |
出版年
2022年 | 133篇 |
2021年 | 287篇 |
2020年 | 196篇 |
2019年 | 326篇 |
2018年 | 383篇 |
2017年 | 316篇 |
2016年 | 330篇 |
2015年 | 377篇 |
2014年 | 479篇 |
2013年 | 746篇 |
2012年 | 996篇 |
2011年 | 1032篇 |
2010年 | 593篇 |
2009年 | 523篇 |
2008年 | 976篇 |
2007年 | 983篇 |
2006年 | 969篇 |
2005年 | 1004篇 |
2004年 | 1018篇 |
2003年 | 965篇 |
2002年 | 879篇 |
2001年 | 441篇 |
2000年 | 433篇 |
1999年 | 413篇 |
1998年 | 232篇 |
1997年 | 224篇 |
1996年 | 171篇 |
1995年 | 170篇 |
1994年 | 131篇 |
1993年 | 153篇 |
1992年 | 278篇 |
1991年 | 270篇 |
1990年 | 291篇 |
1989年 | 259篇 |
1988年 | 232篇 |
1987年 | 193篇 |
1986年 | 248篇 |
1985年 | 209篇 |
1984年 | 188篇 |
1983年 | 175篇 |
1982年 | 145篇 |
1981年 | 140篇 |
1980年 | 157篇 |
1979年 | 180篇 |
1978年 | 158篇 |
1977年 | 144篇 |
1976年 | 120篇 |
1975年 | 145篇 |
1974年 | 157篇 |
1973年 | 155篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
E. Niclas Jonsson Rujia Xie Scott F. Marshall Rosalin H. Arends 《British journal of clinical pharmacology》2016,81(4):688-699
AimsThe aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs. a dosing regimen adjusted by body weight.MethodsIndividual concentration–time data were determined from 1608 patients in four phase 3 studies conducted to assess efficacy and safety of intravenous tanezumab. Patients received two or three intravenous doses (2.5, 5 or 10 mg) every 8 weeks. Blood samples for assessment of tanezumab PK were collected at baseline, 1 h post‐dose and at weeks 4, 8, 16 and 24 (or early termination) in all studies. Blood samples were collected at week 32 in two studies. Plasma samples were analyzed using a sensitive, specific, validated enzyme‐linked immunosorbent assay.ResultsA two compartment model with parallel linear and non‐linear elimination processes adequately described the data. Population estimates for clearance (CL), central volume (V
1), peripheral volume (V
2), inter‐compartmental clearance, maximum elimination capacity (VM) and concentration at half‐maximum elimination capacity were 0.135 l day–1, 2.71 l, 1.98 l, 0.371 l day–1, 8.03 μg day–1 and 27.7 ng ml–1, respectively. Inter‐individual variability (IIV) was included on CL, V
1, V
2 and VM. A mixture model accounted for the distribution of residual error. While gender, dose and creatinine clearance were significant covariates, only body weight as a covariate of CL, V
1 and V
2 significantly reduced IIV.ConclusionsThe small increase in variability associated with fixed dosing is consistent with other monoclonal antibodies and does not change risk : benefit. 相似文献
3.
4.
5.
6.
7.
8.
9.
10.
Several studies have demonstrated that a descending dopaminergic pathway innervates the dorsal and the intermediate gray matter of the spinal cord and have suggested that this pathway is involved in pain modulation and in the control of autonomie functions. Other studies have also demonstrated the presence of dopamine (DA) and DA metabolites as well as of DA receptors in the ventral cord. There is also evidence for the implication of DA in the control of motor functions at the spinal level. The occurrence of a dopaminergic innervation in the ventral horn has been, however, disputed until recently. But recent work has demonstrated that the motoneural cell groups in the ventral horn (lamina IX) are a target for descending dopaminergic fibers. In addition, the possibility that DA is a mediator of primary afferent fibers has also been postulated. Finally, the occurrence of dopaminergic cell bodies has been suggested in the spinal cord. This indicates that DA is probably implicated in a complex manner in spinal functions. In the present paper the possible involvement of DA in sensory and in motor functions at spinal level will be discussed in view of neurochemical observations made in polyarthritic rats, in which pain-related behavior and reduction of locomotor activity associated with a marked decrease in mobility, are observed. 相似文献